.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
AstraZeneca
Fish and Richardson
Covington
UBS
Citi
QuintilesIMS
Daiichi Sankyo
Baxter

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205677

« Back to Dashboard
NDA 205677 describes HETLIOZ, which is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug. Additional details are available on the HETLIOZ profile page.

The generic ingredient in HETLIOZ is tasimelteon. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tasimelteon profile page.

Summary for 205677

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:6

Pharmacology for NDA: 205677

Mechanism of ActionMelatonin Receptor Agonists

Suppliers and Packaging for NDA: 205677

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HETLIOZ
tasimelteon
CAPSULE;ORAL 205677 NDA Vanda Pharmaceuticals Inc. 43068-220 43068-220-01 30 CAPSULE in 1 BOTTLE (43068-220-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Jan 31, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 31, 2019
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Jan 31, 2021
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Dec 9, 2017Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF NON-24-HOUR SLEEP-WAKE DISORDER


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
AstraZeneca
Dow
Deloitte
Teva
Boehringer Ingelheim
Moodys
US Department of Justice
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot